Lynne Fahey McGrath
CIK: 0001866270
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (100.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ALZN
Alzamend Neuro, Inc.
Director
Discretionary Trading P&L
Holdings
About McGrath Lynne Fahey
McGrath Lynne Fahey (SEC CIK 0001866270) files insider reports with the SEC as Director of Alzamend Neuro, Inc. (ALZN).
Signal8 holds 1 ownership filing by McGrath Lynne Fahey, a Form 4, filed on Oct 24, 2025. Those filings report 1 transaction, the latest on Oct 23, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on McGrath Lynne Fahey's filings is in ATLANTA, GA.
Recent filings by McGrath Lynne Fahey
- Oct 23, 2025: Open-market sale of ALZN shares (Form 4, code S).
Other insiders filing for Alzamend Neuro, Inc. (ALZN)
- Hyperscale Data, Inc., Director
- AULT MILTON C III, Director
- Nisser Henry Carl, EVP and General Counsel
- Horne William B., Director
- Oram Jeffrey, Director
- GUSTAFSON MARK, Director